Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-127218
Filing Date
2024-11-14
Accepted
2024-11-14 17:20:09
Documents
18
Period of Report
2024-10-18
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A hura-20241018.htm   iXBRL 8-K/A 60413
2 EX-99.2 hura-ex99_2.htm EX-99.2 123223
3 EX-99.3 hura-ex99_3.htm EX-99.3 608425
4 GRAPHIC img113482602_0.jpg GRAPHIC 37685
5 GRAPHIC img113482602_1.jpg GRAPHIC 24903
6 GRAPHIC img113482602_2.jpg GRAPHIC 46921
7 GRAPHIC img113482602_3.jpg GRAPHIC 24862
8 GRAPHIC img114406123_0.jpg GRAPHIC 12503
  Complete submission text file 0000950170-24-127218.txt   1182725

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20241018.xsd EX-101.SCH 27005
21 EXTRACTED XBRL INSTANCE DOCUMENT hura-20241018_htm.xml XML 6247
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37823 | Film No.: 241464377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)